DrugViu

The project is a legitimate, venture-backed digital health platform (formerly DrugViu, rebranded to ViuHealth in 2022) addressing critical disparities in clinical trials and autoimmune care. While the submission itself is of low quality with inaccurate claims (e.g., 'most people have used my product', 'reach: everyone'), external verification confirms meaningful traction, including seed funding (~$1M+), partnerships with patient advocacy groups, and a community of ~35,000 members. The score reflects high real-world utility and market relevance, heavily penalized for the submission's false traction statements and lack of detail.